Accomplishments in 2013

The SCCF and EpimedX, LLC together developed relationships with additional partners. The international company that manufactures the chemical used in our treatment has provided over $300,000. to further our research. In mid year, Analytical Edge Laboratories, also located in the University of Oklahoma Health Science Center Research Park (formerly Presbyterian Health Foundation Research Park) agreed […]

A day in the life…

The day begins with muted anticipation.  Once each week, veterinarians examine carefully the health of each of the study baboons.   These examinations check of overall health as well as look for physical effects of the study medication.  This hours-long process includes collection of a small amount of blood that is relayed to other scientists who […]

A cure for sickle cell disease from our own bodies…

We are very proud to announce major progress in the search for a cure for sickle cell disease (SCD), the first genetic disease to be understood and a major disease that kills an estimated half-million people world-wide each year. As high as one in every four black persons in certain parts of Africa carries the […]

Peer Review & Validations of SCCF’s Discovery – Our Credentials

Some people have asked, “Your ‘cure’ works in theory, but does it work in practice?” The answer is, “Yes!!!” The key point is that fetal hemoglobin (HbF) has been shown to be preventive for sickle cell disease in nature, in many labs around the world, in many, many repeated experiments and patient trials over the […]

About sickle cell disease…

“Everything we know about genes we learned first about the beta globin gene. Everything we know about molecular disease we first learned about sickle cell disease” Francis Collins, NIH, former Director of the Human Genome Project

Our Research

We have named our approach to curing sickle cell disease Gene Regulation Therapy, and the result is called a phenotypic cure. That is to say, no genes are permanently altered; instead, we use normal bodily signals to turn off the sickle cell gene and activate another gene with the same function in its place. We […]